Table 3

Association of expression of the circulating lncRNA MALAT1 with different parameters among patients with T2DM

VariableFold change in MALAT1 expression among patients with T2DM (mean±SD)P value
Overall expression4.46±2.09
Age (years)
 ≤40 years4.28±2.260.38
 >40 years4.56±1.94
Sex
 Male4.38±2.220.58
 Female4.56±1.94
Hypertension
 Yes4.44±1.990.52
 No4.50±2.25
Nephropathy
 Yes4.42±2.210.65
 No4.50±1.99
Weight loss
 Yes4.85±2.050.003
 No4.02±2.06
Fatigue
 Yes4.37±2.380.33
 No4.55±1.81
Slow wound healing
 Yes4.31±1.970.35
 No4.67±2.26
Retinopathy
 Yes5.02±2.300.01
 No4.18±1.93
Loss of appetite
 Yes4.37±1.950.92
 No4.54±2.21
Smoking
 Yes5.09±2.04<0.0001
 No3.92±1.99
Alcoholism
 Yes5.20±2.05<0.0001
 No3.69±1.86
  • lncRNA, long non-coding RNA; MALAT1, metastasis-associated lung adenocarcinoma transcript 1; T2DM, type 2 diabetes mellitus.